This morning’s transactions show capital moving closer to the operating route. Dangote is buying into the pipeline that can carry fuel from a planned Kenyan refinery, conservation finance is tying money to policy changes over ten years, and global buyers are using control, retained ownership and divestments to make large combinations executable.
Dangote buys the route to market
Dangote Industries acquired 25% of Kenya Pipeline Company. The Financial Times reported a US$335 million purchase price and a separate plan to invest US$1.5 billion in expanding the 1,300 km network. The stake links a planned Lamu refinery to an existing distribution system. Access terms, tariffs, capacity investment and minority governance will determine whether ownership improves the route to market.
Conservation funding is contracted against reform
Kenya and a donor coalition signed the US$160 million Thamani Asili conservation programme. Donors and government are each expected to provide US$80 million over ten years, with funding tied to policy changes under a Project Finance for Permanence model. The transaction turns conservation ambition into a long-term funding and delivery compact.
Trade finance capacity moves closer to local firms
The African Development Bank approved a facility for Cameroon comprising a trade-finance credit line of up to €30 million and a €10 million guarantee. The useful measure will not be the approved limit alone, but how much qualified trade reaches the facility, how quickly it is used and whether local SMEs gain access.
EQT takes diagnostics private with institutional backing
EQT agreed to acquire Qiagen for about US$10.8 billion, valuing the molecular-testing company at roughly US$12.1 billion including debt. Affiliates of ADIA and CPP Investments are backing the transaction. The take-private now needs a clear portfolio and research-investment plan, not simply financing certainty.
Cencora uses retained ownership to consolidate oncology care
Cencora agreed to acquire American Oncology Network in a transaction valued at up to US$2.4 billion. Selected AON shareholders may retain as much as 25%. That rollover can preserve clinical alignment, but only if physician incentives, governance and operating autonomy remain coherent after closing.
Two divestments carry a US$25 billion merger toward approval
AkzoNobel and Axalta are moving their US$25 billion merger toward approval through two proposed divestments: AkzoNobel’s European vehicle-refinishing business and Axalta’s US wood-finishes division. The remedy is now an operating separation, with perimeter, buyer and transition-services readiness on the merger’s critical path.
What the structure tells us
Africa’s transactions this morning put infrastructure and implementation inside the investment thesis. A refinery needs a route to market, conservation funding needs policy delivery, and a credit facility needs actual trade flows. The capital becomes useful only when the operating pathway is explicit.
The global deals reach the same point through different structures. Rollover equity, institutional co-investment and regulatory divestments are not side notes; they are the machinery that keeps a transaction financeable, aligned and capable of closing. That is why 0to1 follows the transaction rather than only the headline.
transactions · infrastructure · minority investment · blended finance · trade finance · take-private · M&A · carve-outs